Biological mechanisms behind RF safety limits

An external RF field, an internal absorption rate and a measured biological response are different parts of an evidence chain. To interpret a claim, follow the coupling from field to tissue, identify the physical interaction, and ask what the observation establishes. A detectable response is not automatically an adverse health effect; a missing temperature change is not automatically proof that no heating occurred.

Build on RF field quantities and time averaging. Here the aim is to connect those quantities to mechanisms and to evaluate the strength of an inference.

Follow the interaction pathway

An external field induces internal fields and currents according to frequency, geometry, tissue properties and nearby conductors. Internal power absorption can cause heating. At the lower RF frequencies, induced electric fields can also stimulate excitable tissue. Which restrictions apply must come from the adopted framework, not a single label such as “low frequency” or “non-thermal”.

The ICNIRP 2020 RF guidelines provide a concrete example. They include heating-related restrictions across 100 kHz–300 GHz, with additional induced-field restrictions for stimulation from 100 kHz–10 MHz. Their Table 2 retains whole-body SAR across that RF range, while the local heating metric changes above 6 GHz. Thus the mechanisms overlap at the lower RF edge; it is incorrect to assign the entire lower band to stimulation alone.

These distinctions are a framework example, not a replacement for the edition and jurisdiction governing a particular assessment.

Separate heating from observed temperature

SAR is a power absorption rate per mass. For a uniform element with constant SAR and specific heat capacity c, a short exposure with negligible heat loss gives Δ T ≈ (SAR t)/c. Conduction, blood flow and other heat exchange change the actual temperature response. A bulk measurement can also miss a local gradient or a short transient. A study’s “no heating” claim therefore needs a measurement location, resolution, response time and uncertainty, rather than only the room temperature.

Evaluate the claim before the headline

First define the observation: what endpoint changed, by how much, and with what uncertainty? Establish the internal dose using a validated measurement or coupling model. Document frequency, waveform, geometry, duration, field uniformity and operating state; “low field” without those facts is not a reproducible exposure definition.

Next examine competing explanations. Were exposed and sham samples handled in the same way? Were relevant temperatures monitored with adequate placement, resolution and response time? Could equipment heat or handling explain the outcome? Were the endpoint and analysis specified before examining many possible outcomes?

Then ask whether the result repeats under comparable exposure conditions. Replication strengthens an inference but does not by itself prove health harm or transfer the result to a different frequency, dose or biological system. An adverse-effect claim needs an evidenced link from the measured endpoint to harm, including dose response and applicability.

Use “non-thermal” precisely. It may mean no measured bulk temperature increase, an effect not explained by the thermal controls performed, or a proposed mechanism distinct from heating. Those are progressively stronger claims, requiring progressively more evidence. An unexplained finding is not evidence of one particular explanation simply because another has not been observed.

Write a bounded evidence statement

State the endpoint and exposure conditions, the quality of dosimetry and controls, the observed result and the unresolved inference. Distinguish “not established by this study” from “impossible”. One incomplete experiment neither proves a new adverse mechanism nor proves the absence of all possible effects.

Continue with epidemiological evidence for population studies and risk communication for explaining uncertainty to stakeholders.

Knowledge check

Exercises